• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质包裹:关联、聚集及药物设计的分子标记

Protein wrapping: a molecular marker for association, aggregation and drug design.

作者信息

Fernández Ariel, Crespo Alejandro

机构信息

Department of Bioengineering, Rice University, Houston, TX 77005, USA.

出版信息

Chem Soc Rev. 2008 Nov;37(11):2373-82. doi: 10.1039/b804150b. Epub 2008 Sep 15.

DOI:10.1039/b804150b
PMID:18949110
Abstract

In this tutorial review we survey the concept of protein wrapping from a physico-chemical perspective. Wrapping is introduced as an indicator of the packing quality of protein structure. Thus, while a well-wrapped protein is sustainable in isolation, a poorly wrapped protein is reliant on binding partnerships to maintain its structural integrity. At a local level, wrapping is indicative of the extent of solvent exposure of the amide-carbonyl hydrogen bonds of the protein backbone. Poorly wrapped hydrogen bonds, the so-called dehydrons, are shown to represent structural vulnerabilities. These singularities are sticky, hence promoters of protein associations. We also focus on severely under-wrapped protein structures that belong to an order/disorder twilight. Such proteins are shown to be prone to aggregate. Finally, we survey the recent exploitation of dehydrons as targetable features to promote specificity in drug-based cancer therapy. Dehydrons prove to be valuable targets to reduce side effects and enhance drug safety.

摘要

在本教程综述中,我们从物理化学角度审视蛋白质包裹的概念。包裹被引入作为蛋白质结构堆积质量的一个指标。因此,虽然包裹良好的蛋白质在孤立状态下是可持续的,但包裹不佳的蛋白质则依赖于结合伙伴关系来维持其结构完整性。在局部层面,包裹表明了蛋白质主链酰胺-羰基氢键的溶剂暴露程度。包裹不佳的氢键,即所谓的脱水子,被证明代表结构脆弱性。这些奇点具有粘性,因此是蛋白质缔合的促进剂。我们还关注属于有序/无序过渡态的严重包裹不足的蛋白质结构。此类蛋白质被证明易于聚集。最后,我们综述了最近将脱水子作为可靶向特征加以利用,以促进基于药物的癌症治疗的特异性。事实证明,脱水子是减少副作用和提高药物安全性的有价值靶点。

相似文献

1
Protein wrapping: a molecular marker for association, aggregation and drug design.蛋白质包裹:关联、聚集及药物设计的分子标记
Chem Soc Rev. 2008 Nov;37(11):2373-82. doi: 10.1039/b804150b. Epub 2008 Sep 15.
2
Dehydration propensity of order-disorder intermediate regions in soluble proteins.可溶性蛋白质中有序-无序中间区域的脱水倾向。
J Proteome Res. 2007 Sep;6(9):3519-26. doi: 10.1021/pr070208k. Epub 2007 Aug 2.
3
Functionality of wrapping defects in soluble proteins: what cannot be kept dry must be conserved.可溶性蛋白质中包裹缺陷的功能:不能保持干燥的必须加以保存。
J Mol Biol. 2004 Mar 19;337(2):477-83. doi: 10.1016/j.jmb.2004.01.050.
4
Redesigning kinase inhibitors to enhance specificity.重新设计激酶抑制剂以提高特异性。
J Med Chem. 2008 Aug 28;51(16):4890-8. doi: 10.1021/jm800453a. Epub 2008 Aug 5.
5
Solvent-exposed backbone loosens the hydration shell of soluble folded proteins.暴露于溶剂中的主链会使可溶性折叠蛋白的水化层松弛。
J Chem Phys. 2007 Jun 28;126(24):245103. doi: 10.1063/1.2745795.
6
Proteins with H-bond packing defects are highly interactive with lipid bilayers: Implications for amyloidogenesis.具有氢键堆积缺陷的蛋白质与脂质双层具有高度相互作用:对淀粉样蛋白生成的影响。
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2391-6. doi: 10.1073/pnas.0335642100. Epub 2003 Feb 18.
7
[Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].[药物分子设计策略:分子宏观性质与微观结构的统一]
Yao Xue Xue Bao. 2008 Mar;43(3):227-33.
8
Analysis of protein folding and function using backbone modified proteins.使用主链修饰蛋白分析蛋白质折叠与功能。
Bioorg Chem. 2004 Oct;32(5):438-49. doi: 10.1016/j.bioorg.2004.06.011.
9
Inhibitor design by wrapping packing defects in HIV-1 proteins.通过包裹HIV-1蛋白中的堆积缺陷进行抑制剂设计。
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11640-5. doi: 10.1073/pnas.0404641101. Epub 2004 Aug 2.
10
Protein packing defects "heat up" interfacial water.蛋白质堆积缺陷使界面水“升温”。
Eur Phys J E Soft Matter. 2013 Jun;36(6):62. doi: 10.1140/epje/i2013-13062-7. Epub 2013 Jun 25.

引用本文的文献

1
Solvent effects in anion recognition.阴离子识别中的溶剂效应。
Nat Rev Chem. 2024 Apr;8(4):256-276. doi: 10.1038/s41570-024-00584-4. Epub 2024 Mar 6.
2
Engineered Binding Microenvironments in Halogen Bonding Polymers for Enhanced Anion Sensing.基于卤素键聚合物的工程化结合微环境用于增强阴离子传感。
Angew Chem Int Ed Engl. 2023 Mar 27;62(14):e202300867. doi: 10.1002/anie.202300867. Epub 2023 Feb 23.
3
A conserved Trp residue in HwBR contributes to its unique tolerance toward acidic environments.HwBR 中的保守色氨酸残基有助于其对酸性环境的独特耐受性。
Biophys J. 2022 Aug 16;121(16):3136-3145. doi: 10.1016/j.bpj.2022.07.009. Epub 2022 Jul 8.
4
Novel Stilbene-Nitroxyl Hybrid Compounds Display Discrete Modulation of Amyloid Beta Toxicity and Structure.新型芪-硝酰基杂化化合物对β-淀粉样蛋白毒性和结构具有离散调制作用。
Front Chem. 2022 May 26;10:896386. doi: 10.3389/fchem.2022.896386. eCollection 2022.
5
Anion Recognition by a Pincer-Type Host Constructed from Two Polyamide Macrocyclic Frameworks Jointed by a Photo-Addressable Azobenzene Switch.由光寻址偶氮苯开关连接的两个聚酰胺大环框架构建的钳型主体对阴离子的识别
Materials (Basel). 2022 Jan 17;15(2):692. doi: 10.3390/ma15020692.
6
Therapeutically Targeted Destabilization of the Quaternary Structure of the Spike Protein in the Dominant G614 Strain of SARS-CoV-2.对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)优势 G614 株刺突蛋白四级结构进行治疗性靶向破坏。
ACS Pharmacol Transl Sci. 2020 Sep 1;3(5):1027-1029. doi: 10.1021/acsptsci.0c00114. eCollection 2020 Oct 9.
7
Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.新型冠状病毒刺突蛋白中D614G突变的结构影响:增强的传染性及治疗契机
ACS Med Chem Lett. 2020 Aug 17;11(9):1667-1670. doi: 10.1021/acsmedchemlett.0c00410. eCollection 2020 Sep 10.
8
Aggregation tendencies in the p53 family are modulated by backbone hydrogen bonds.p53 家族的聚集倾向受骨架氢键调节。
Sci Rep. 2016 Sep 7;6:32535. doi: 10.1038/srep32535.
9
M1 RNA is important for the in-cell solubility of its cognate C5 protein: Implications for RNA-mediated protein folding.M1 RNA对其同源C5蛋白在细胞内的溶解性很重要:对RNA介导的蛋白质折叠的启示。
RNA Biol. 2015;12(11):1198-208. doi: 10.1080/15476286.2015.1096487. Epub 2015 Oct 30.
10
Structure and mechanism of action of tau aggregation inhibitors.tau蛋白聚集抑制剂的结构与作用机制。
Curr Alzheimer Res. 2014;11(10):918-27. doi: 10.2174/1567205011666141107150331.